Thursday, July 9, 2020

Cipla rises 1.3% after launching Covid-19 treatment drug remdesivir as Cipremi at Rs4,000 in India

Last month, the company launched remdesivir under its brand name CIPREMI.

from India Infoline News Service https://ift.tt/325wvo6
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)